ASR Nederland (ASRNL) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
13 Apr, 2026Executive summary
Completed integration of Aegon NL, achieving major milestones and creating a leading insurer in the Netherlands, with significant cost synergies and strengthened market position.
Achieved strong financial performance with double-digit growth in key metrics, supported by business growth, higher investment margins, and disciplined execution in pension buy-outs and acquisitions.
Raised capital returns to shareholders, including a 9.3% dividend increase and substantial share buybacks, with 75% of OCC allocated to shareholders.
Maintained disciplined approach to M&A and buyouts, focusing on value over volume and profitability.
Leadership transition announced, with CEO Jos Baeten stepping down and Ingrid de Zwart set to take over.
Financial highlights
OCC increased 10.2% to €1,315 million, driven by business growth and higher investment margin.
Operating result rose 11.9% to €1,637 million; operating ROE at 14.1%, above 12% hurdle.
Solvency II ratio improved by 20 points to 218%, supported by PIM implementation.
Dividend per share increased by 9.3% to €3.41; share buybacks of €230 million completed and €175 million announced for 2026.
Combined ratio Non-life (excl. Health) at 92.2%, at the lower end of the target range.
Outlook and guidance
On track to achieve OCC target of €1,350 million for 2026, with growth expected from business expansion, buyouts, and synergies.
Dividend policy aims for mid- to high single-digit growth; cumulative share buyback program of €525 million for 2024-2026.
Continued focus on disciplined capital deployment and maintaining strong solvency.
Customer satisfaction, sustainability, and diversity targets progressing ahead of schedule.
Latest events from ASR Nederland
- Targets €1.35bn OCC, >€2.5bn capital return, and ESG-driven growth through 2026.ASRNL
CMD 20243 Feb 2026 - Operating result up 47–50% to €677m, OCC €658m, Solvency II ratio 180–181% (196% pro forma).ASRNL
H1 202423 Jan 2026 - Operating result up 46.7% to €1,428m, OCC and solvency strengthened, integration on track.ASRNL
H2 20248 Jan 2026 - Operating result up 22% to €826m, Solvency II at 203%, and €1.27 interim dividend declared.ASRNL
H1 202523 Nov 2025